Treatment Strategies and Survival Outcomes of Patients with EGFR-mutated NSCLC and leptomeningeal metastasis

被引：0
|
作者：
Fan, Y. [1 ]
Wu, H. [1 ]
Chen, K. [1 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Leptomeningeal metastases; EGFR TKI resistance; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-30
引用
收藏
页码：S652 / S652
页数：1
相关论文
共 50 条
  • [21] Gefitinib Approved for EGFR-Mutated NSCLC
    不详
    CANCER DISCOVERY, 2015, 5 (09) : 896 - 896
  • [22] Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
    J L Kuiper
    S M S Hashemi
    E Thunnissen
    P J F Snijders
    K Grünberg
    E Bloemena
    D Sie
    P E Postmus
    D A M Heideman
    E F Smit
    British Journal of Cancer, 2016, 115 : 1504 - 1512
  • [23] Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
    Kuiper, J. L.
    Hashemi, S. M. S.
    Thunnissen, E.
    Snijders, P. J. F.
    Grunberg, K.
    Bloemena, E.
    Sie, D.
    Postmus, P. E.
    Heideman, D. A. M.
    Smit, E. F.
    BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1504 - 1512
  • [24] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Masahiro Tsuboi
    Roy S. Herbst
    Thomas John
    Terufumi Kato
    Margarita Majem
    Christian Grohé
    Jie Wang
    Jonathan W. Goldman
    Shun Lu
    Filippo de Marinis
    Frances A. Shepherd
    Ki Hyeong Lee
    Nhieu Thi Le
    Arunee Dechaphunkul
    Dariusz Kowalski
    Laura Bonanno
    Manuel Dómine
    Lynne Poole
    Ana Bolanos
    Yuri Rukazenkov
    Yi-Long Wu
    Targeted Oncology, 2024, 19 : 131 - 134
  • [25] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    John, Thomas
    Kato, Terufumi
    Majem, Margarita
    Grohe, Christian
    Wang, Jie
    Goldman, Jonathan W.
    Lu, Shun
    de Marinis, Filippo
    Shepherd, Frances A.
    Lee, Ki Hyeong
    Le, Nhieu Thi
    Dechaphunkul, Arunee
    Kowalski, Dariusz
    Bonanno, Laura
    Domine, Manuel
    Poole, Lynne
    Bolanos, Ana
    Rukazenkov, Yuri
    Wu, Yi-Long
    TARGETED ONCOLOGY, 2024, 19 (02) : 131 - 134
  • [26] Osimertinib in patients with EGFR-mutated NSCLC and leptomeningeal or brain metastases: Results of the IFCT-1804 ORBITAL trial
    Planchard, D.
    Toffart, A. C.
    Flandin, A-C. Madroszyk
    Wislez, M.
    Martinez, S.
    Monnet, I.
    Hiret, S.
    Gounant, V.
    Metivier, A-C.
    Domblides, C.
    Giroux-Leprieur, E.
    Huchot, E.
    Tomasini, P.
    Mascaux, C.
    Carmier, D.
    Langlais, A.
    Morin, F.
    Westeel, V.
    Cortot, A.
    ANNALS OF ONCOLOGY, 2023, 34
  • [27] Treatment Adherence Disparities and Clinical Outcomes of Osimertinib among Ethnic-Minority Patients with EGFR-Mutated NSCLC
    Lee, M.
    Miao, E.
    Zhang, C.
    Xue, X.
    Tuckman, S.
    Halmos, B.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S331 - S332
  • [28] Efficacy of dacomitinib in patients with EGFR-mutated NSCLC and brain metastases
    Zhang, Jinyao
    Wang, Yan
    Liu, Ziling
    Wang, Lin
    Yao, Yu
    Liu, Yutao
    Hao, Xue Zhi
    Wang, Jianyang
    Xing, Puyuan
    Li, Junling
    THORACIC CANCER, 2021, 12 (24) : 3407 - 3415
  • [29] Clinical analysis of the presence of comutations in patients with EGFR-mutated NSCLC
    Rubio, Jaime
    Santolaya, Carlota
    Fernandez, Marina
    Villalba, Paula Lucia
    Avedillo, Mercedes
    Garcia-Foncillas, Jesus
    Domine, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC
    Zheng, Mei-Mei
    Li, Yang-Si
    Tu, Hai-Yan
    Jiang, Ben-Yuan
    Yang, Jin-Ji
    Zhou, Qing
    Xu, Chong-Rui
    Yang, Xiao-Rong
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 250 - 258
12345